Bank of Montreal’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bank of Montreal’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-50,000	Closed	-$344K	–	4338
2014 Q4	$344K	Hold	50,000	–	–	﹤0.01%	2238
2014 Q3	$270K	Hold	50,000	–	–	﹤0.01%	2386
2014 Q2	$319K	Sell	50,000 -50,000	-50%	-$344K	﹤0.01%	2312
2014 Q1	$806K	Buy	100,000 +70,000	+233%	+$545K	﹤0.01%	1783
2013 Q4	$205K	Sell	30,000 -25,000	-45%	-$135K	﹤0.01%	2233
2013 Q3	$1.01M	Buy	+55,000	New	+$1.07M	﹤0.01%	1447

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Bank of Montreal's ARIA Position: Q1 2017 in Review

Bank of Montreal sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 3,460 shares — an estimated $47K sold.

Bank of Montreal first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $3.17M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Bank of Montreal reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Bank of Montreal sold 3,460 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $47K.
Bank of Montreal first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
Bank of Montreal's Ariad Pharmaceuticals Inc position peaked at $3.17M in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Bank of Montreal's 13F filing for Q1 2017, filed 11 Apr 2017.